The anatomical basis of intestinal immunity

Immunological Reviews

Volumn 156, Issue , 1997, Pages 145-166

  Mowat, Allan McI ^a,b   Viney, Joanne L ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTING CELL; ENTERITIS; FOOD ALLERGY; FUNCTIONAL ANATOMY; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; INTESTINE LYMPHATIC TISSUE; LAMINA PROPRIA; LYMPHOCYTE; LYMPHOCYTE DIFFERENTIATION; MESENTERY LYMPH NODE; MUCOSAL IMMUNITY; PEYER PATCH; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0030900764     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1997.tb00966.x     Document Type: Review

References (278)

1. Guy-Grand D, Vassalli P. Gut intraepithelial T lymphocytes. Curr Opin Immunol 1993;5:247-252.
2. Neumann B, Luz A, Pfeffer K, Holzmann B. Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J Exp Med 1996;184:259-264.
3. Banks TA, et al. Lymphotoxin-α-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol 1995;155:1685-1693.
4. Eugster H-P, et al. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice. Int Immunology 1996;8:23-36.
5. De Togni P, et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994;264:703-707.
6. Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS. Surface lymphotoxin α/β complex is required for the development of peripheral lymphoid organs. J Exp Med 1996;184:1999-2006.
7. Lefrancois L. Basic aspects of intraepithelial lymphocyte immunobiology. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, eds. Handbook of mucosal immunology. San Diego: Academic Press Inc, 1994:287-298.
8. Eckmann L, Jung HC, Schurer-Maly C, Panja A, Morzycka-Wroblewska E, Kagnoff MF. Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 1993;105:1689-1697.
9. Koyama S, Podolsky DK. Differential expression of transforming growth factors α and β in rat intestinal epithelial cells. J Clin Invest 1989;83:1768-1773.
10. Barnard J, Warwick GJ, Gold LI. Localization of transforming growth factor beta isoforms in the normal murine small intestine and colon. Gastroenterology 1993;105:67-73.
11. McGee DW Vitkus SJ. IL-4 enhances IEC-6 intestinal epithelial cell proliferation yet has no effect on IL-6 secretion. Clin Exp Immunol 1996;105:274-277.
12. McGee DW, Bamberg T, Vitkus SJ, McGhee JR. A synergistic relationship between TNF-α, IL-1 β, and TGF-β1 on IL-6 secretion by the IEC-6 intestinal epithelial cell line. Immunology 1995;86:6-11.
13. Schuerer-Maly C, Eckmann L, Kagnoff MF, Falco T, Maly FE. Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology 1994;81:85-91.
14. Stadnyk A, Sisson GR, Waterhouse CC. IL-1α is constitutively expressed in the rat intestinal epithelial cell line IEC-6. Exp Cell Res 1995;220:298-303.
15. Panja A, Siden E, Mayer L. Synthesis and regulation of accessory/proinflammatory cytokines by intestinal epithelial cells. Clin Exp Immunol 1995;100:298-305.
16. Mowat AM, Garside P, Fitton LA, Higley HR, Carlino JA. Regulatory activity of endogenous and exogenous transforming growth factor β in experimental intestinal immunopathology. Growth Factors 1996;13:75-85.
17. Watanabe M, et al. Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. J Clin Invest 1995;95:2945-2953.
18. Planchon S, Martins CA, Guerrant RL, Roche JK. Regulation of intestinal epithelial barrier function by TGF-β 1. Evidence for its role in abrogating the effect of a T cell cytokine. J Immunol 1994;153:5730-5739.
19. Madara J, Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989;83:724-727.
20. McGee D, Vitkus SJ. IL-4 enhances IEC-6 intestinal epithelial cell proliferation yet has no effect on IL-6 secretion. Clin Exp Immunol 1996;105:274-277.
21. Colgan SP, et al. IL-4 directly modulates function of a model human intestinal epithelium. J Immunol 1994;153:2122-2129.
22. Sartor R. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994;106:533-539.
23. Rodriguez P, Heyman M, Candalh C, Blaton MA, Bouchaud C. Tumour necrosis factor-α induces morphological and functional alterations of intestinal HT29 cl.19A cell monolayers. Cytokine 1995;7:441-448.
24. Ziambaras T, Rubin DC, Perlmutter DH. Regulation of sucrase-isomaltase gene expression in human intestinal epithelial cells by inflammatory cytokines. J Biol Chem 1996;271:1237-1242.
25. Zund G, Madara JL, Dzus AL, Awtrey CS, Colgan SP. Interleukin-4 and interleukin-13 differentially regulate epithelial chloride secretion. J Biol Chem 1996;271:7460-7464.
26. Phillips-Quagliata JM, Lamm ME. Migration of lymphocytes in the mucosal immune system. In: Husband AJ, ed. Migration and homing of lymphoid cells. Boca Raton: CRC Press, 1988:53-75.
27. Lamm ME. Cellular aspects of immunoglobulin A. Adv Immunol 1976;22:223-290.
28. Hamann A, Andrew DP, Jablonski Westrich D, Holzmann B, Butcher EC. Role of α4-integrins in lymphocyte homing to mucosal tissues in vivo. J Immunol 1994;152:3282-3293.
29. Berlin C, et al. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993;74:185-195.
30. Shaw SK BM. The β7 integrins in mucosal homing and retention. Semin Immunol 1995;7:335-342.
31. Farstad I, Halstensen TS, Lazarovits AI, Norstein J, Fausa O, Brandtzaeg P. Human intestinal B-cell blasts and plasma cells express the mucosal homing receptor integrin α4β7. Scand J Immunol 1995;42:662-672.
32. Farstad I, Halstensen TS, Lien B, Kilshaw PJ, Lazarovitz AI, Brandtzaeg P. Distribution of β7 integrins in human intestinal mucosa and organized gut-associated lymphoid tissue. Immunology 1996;89:227-237.
33. Wagner N, et al. Critical role for β7 integrins in formation of the gut-associated lymphoid tissue. Nature 1996;382:366-370.
34. Viney JL, et al. Mucosal addressin cell adhesion molecule-1. A structural and functional analysis demarcates the integrin binding motif. J Immunol 1996;157:2488-2497.
35. Bargatze R, Jutila MA, Butcher EC. Distinct roles of L-selectin and integrins α4β7 and LFA-1 in lymphocyte homing to Peyer's patch-HEV in situ: the multistep model confirmed and refined. Immunity 1995;3:99-108.
36. McDermott MR, Bienenstock J. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J Immunol 1979;122:1892-1898.
37. Mestecky J, Abraham R, Ogra PL. Common mucosal immune system and strategies for the development of vaccines effective at the mucosal surfaces. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, eds. Handbook of mucosal immunology. San Diego: Academic Press Inc, 1994:357-372.
38. Tanaka T, Ohtsuka Y, Yagita H, Shiratori Y, Omata M, Okumura K. Involvement of α1 and α4 integrins in gut mucosal injury of graft-versus-host disease. Int Immunol 1995;7:1183-1189.
39. Kraal G, Schornagel K, Streeter PR, Holzmann B, Butcher EC. Expression of the mucosal vascular addressin, MAdCAM-1, on sinus-lining cells in the spleen. Am J Pathol 1995;147:763-771.
40. Faveeuw C, Gagnerault MC, Lepault F. Expression of homing and adhesion molecules in infiltrated islets of Langerhans and salivary glands of nonobese diabetic mice. J Immunol 1994;152:5969-5978.
41. Hanninen A, et al. Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J Clin Invest 1993;92:2509-2515.
42. Schaible UE, Vestweber D, Butcher EG, Stehle T, Simon MM. Expression of endothelial cell adhesion molecules in joints and heart during Borrelia burgdorferi infection of mice. Cell Adhes Commun 1994;6:465-479.
43. Bland PW, Warren LG. Antigen presentation by epithelial cells of rat small intestine. II. Selective induction of suppressor T cells. Immunology 1986;58:9-14.
44. Mayer L, Shlien R. Evidence for function of Ia molecules on gut epithelial cells in man. J Exp Med 1987;166:1471-1483.
45. Trier J. Structure and function of intestinal M cells. Gastroenterol Clin North Am 1991;20:531-547.
46. Gebert A, Rothkotter HJ, Pabst R. M cells in Peyer's patches of the intestine. Int Rev Cytol 1996;167:91-159.
47. Jones B, Ghori N, Falkow S. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J Exp Med 1994;180:15-23.
48. Jones B, Pascopella L, Falkow S. Entry of microbes into the host: using M cells to break the mucosal barrier. Curr Opin Immunol 1995;7:474-478.
49. Ermak T, Dougherty EP, Bhagat HR, Kabok Z, Pappo J. Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer's patch M cells. Cell Tissue Res 1995;279:433-436.
50. Grutzkau A, Hanski C, Hahn H, Riecken EO. Involvement of M cells in the bacterial invasion of Peyer's patches: a common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria. Gut 1990;31:1011-1015.
51. Owen RL. M cells - entryways of opportunity for enteropathogens. J Exp Med 1994;180:7-9.
52. Kato T, Owen, RL. Structure and function of intestinal mucosal epithelium. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, eds. Handbook of mucosal immunology. San Diego: Academic Press Inc, 1994:11-26.
53. Keren DF. Antigen processing in the mucosal immune system. Semin Immunol 1992;4:217-226.
54. Wilders MM, Sminia T, Janse EM. Ontogeny of non-lymphoid and lymphoid cells in the rat gut with special reference to large mononuclear Ia-positive dendritic cells. Immunology 1983;50:303-314.
55. + dendritic cell population in mouse Peyer's patches. Eur J Immunol 1996;26:1801-1806.
56. Kelsall B, Strober W. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J Exp Med 1996;183:237-247.
57. Richman L, Graeff, AS, Strober, W. Antigen presentation by macrophage-enriched cells from the mouse Peyer's patch. Cell Immunol 1981;62:110-118.
58. Liu L, MacPherson GG. Rat intestinal dendritic cells: immunostimulatory potency and phenotypic characterization. Immunology 1995;85:88-93.
59. Spalding D, Williamson SI, McGhee JR, Koopman WJ. Peyer's patch dendritic cells: isolation and functional comparison with murine spleen dendritic cells. Immunobiology 1984;168:380-390.
60. Mayrhofer G, Pugh CW, Barclay AN. The distribution, ontogeny and origin in the rat of Ia-positive cells with dendritic morphology and of Ia antigen in epithelia, with special reference to the intestine. Eur J Immunol 1983;13:112-122.
61. Pavli P, Woodhams CE, Doe WF, Hume DA. Isolation and characterization of antigen-presenting dendritic cells from the mouse intestinal lamina propria. Immunology 1990;70:40-47.
62. Maric I, Holt PG, Perdue MH, Bienenstock J. Class II MHC antigen (Ia)-bearing dendritic cells in the epithelium of the rat intestine. J Immunol 1996;156:1408-1414.
63. Liu L, MacPherson GG. Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. J Exp Med 1993;177:1299-1307.
64. MacPherson G, Jenkins CD, Stein MJ, Edwards C. Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence. J Immunol 1995;154:1317-1322.
65. Harper H, Cochrane L, Williams NA. The role of small intestinal antigen-presenting cells in the induction of T-cell reactivity to soluble protein antigens: association between aberrant presentation in the lamina propria and oral tolerance. Immunology 1996;89:449-456.
66. Galliaerde V, Desvignes C, Peyron E, Kaiserlian D. Oral tolerance to haptens: intestinal epithelial cells from 2,4-dinitrochlorobenzene-fed mice inhibit hapten-specific T cell activation in vitro. Eur J Immunol 1995;25:1385-1390.
67. + T cells. Eur J Immunol 1989;19:1513-1519.
68. Panja AM, Mayer L. Diversity and function of antigen-presenting cells in mucosal tissues. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, eds. Handbook of mucosal immunology. San Diego: Academic Press Inc, 1994:177-183.
69. Sanderson I, Ouellette AJ, Carter EA, Walker WA, Harmatz PR. Differential regulation of B7 mRNA in enterocytes and lymphoid cells. Immunology 1993;79:434-438.
70. Bloom S, Simmons D, Jewell DP. Adhesion molecules intercellular adhesion molecule-1 (ICAM-1), ICAM-3 and B7 are not expressed by epithelium in normal or inflamed colon. Clin Exp Immunol 1995;101:157-163.
71. Dippold W, Wittig B, Schwaeble W, Mayet W, Meyer zum Buschenfelde KH. Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells. Gut 1993;34:1593-1597.
72. Sloan-Lancaster J, Allen PM. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol 1996;14:1-27.
73. Hershberg R, et al. Expression of the thymus leukemia antigen in mouse intestinal epithelium. Proc Natl Acad Sci USA 1990;87:9727-9731.
74. Blumberg R, et al. Expression of a nonpolymorphic MHC class I-like molecule CD1d by human intestinal epithelial cells. J Immunol 1991;147:2518-2524.
75. Balk S, et al. β2-microglobulin-independent MHC class Ib molecule expressed by human intestinal epithelium. Science 1994;265:259-262.
76. Balk SP, et al. Oligodonal expansion and CD1 recognition by human intestinal intraepithelial lymphocytes. Science 1991;253:1411-1415.
77. Blumberg R, Gerdes D, Chott A, Porcelli SA, Balk SP. Structure and function of the CD1 family of MHC-like cell surface proteins. Immunol Rev 1995;147:5-29.
78. Cheroutre H, et al. Antigen-presenting function of the TL antigen and mouse CD1 molecules. Immunol Rev 1995;147:31-52.
79. Panja A, Blumberg RS, Balk SP, Mayer L. CD1d is involved in T cell-intestinal epithelial cell interactions. J Exp Med 1993;178:1115-1119.
80. + T cell activation is mediated through CD8 and the activation of CD8-associated p56lck. J Exp Med 1995;182:1079-1088.
81. Brandtzaeg P, Krajci P, Lamm ME, Kaetzel CS. Epithelial and hepatobiliary transport of polymeric immunoglobulins. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, eds. Handbook of mucosal immunology. San Diego: Academic Press Inc, 1994:113-137.
82. James SP, Fiochhi C, Graeff AS, Strober W. Phenotypic analysis of lamina propria lymphocytes. Predominance of helper-inducer and cytolytic T-cell phenotypes and deficiency of suppressor-inducer phenotypes in Crohn's disease and control patients. Gastroenterology 1986;91:1483-1489.
83. Schieferdecker HL, Ullrich R, Hirseland H, Zeitz M. T cell differentiation antigens on lymphocytes in the human intestinal lamina propria. J Immunology 1992;149:2816-2822.
84. James SP, Zeitz M. Human gastrointestinal mucosal T cells. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, eds. Handbook of mucosal immunology. San Diego: Academic Press Inc, 1994:275-285.
85. Hurst S, Barrett TA. T-cell responses to enteric antigens. Semin Gastrointest Dis 1996;7:118-123.
86. Abreu-Martin MT, Torgon SR. Regulation of immune responses of the intestinal mucosa. Critical Rev in Immunol 1996;16:277-309.
87. Pirzer UC, Schuurman G, Post S, Betzler M, Meuer SC. Differential responsiveness to CD3 Ti vs CD2-dependent activation of human intestinal T lymphocytes. Eur J Immunol 1990;20:2339-2344.
88. + T cells that secrete IFN-γ and IL-5. J Immunol 1990;145:68-77.
89. Targan S, Deem RL, Liu M, Wang S, Nel A. Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway. J Immunol 1995;154:664-675.
90. Bailey M, Hall L, Bland PW, Stokes CR. Production of cytokines by lymphocytes from spleen, mesenteric lymph node and intestinal lamina propria of pigs. Immunology 1994;82:577-583.
91. Elson CO, Derztbaugh MT. Mucosal adjuvants. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, eds. Handbook of mucosal immunology. San Diego: Academic Press Inc, 1994:391-102.
92. Xu-Amano J, et al. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 1993;178:1309-1320.
93. Marinaro M, et al. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper (TH2) cells and IL-4. J Immunology 1995;155:4621-4629.
94. Hörnquist E, Lycke N. Cholera toxin adjuvant greatly promotes antigen priming of T cells. Eur J Immunol 1993;23:2136-2143.
95. Hörnquist E, Lycke N, Czerkinsky C, Holmgren J. Cholera toxin and cholera B subunit as oral mucosal adjuvant and antigen carrier systems. In: O'Hagan DT, ed. Novel delivery systems for oral vaccines. Boca Raton: CRC Press Inc, 1994:157-173.
96. Vajdy M, Kosco-Vilbois MH, Kopf M, Kohler G, Lycke N. Impaired mucosal immune responses in Interleukin 4-targeted mice. J Exp Med 1995;181:41-53.
97. VanCott JL, et al. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages and derived cytokines following oral immunisation with live recombinant Salmonella. J Immunology 1996;156:1504-1514.
98. Al-Dawoud A, Nakshabendi I, Foulis A, Mowat AMcI. Immunohistochemical analysis of mucosal γ-interferon production in coeliac disease. Gut 1992;33:1482-1486.
99. Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT. Interleukin-2- and interferon-γ-secreting T cells in normal and diseased human intestinal mucosa. Immunology 1993;78:127-131.
100. Nilsen E, Lundin KE, Krajci P, Scott H, Sollid LM, Brandtzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon γ. Gut 1995;37:766-776.
101. Elson C, et al. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J Immunol 1996;157:2174-2185.
102. Davies MDJ, Parrott DMV. The early appearance of specific cytotoxic T cells in murine gut mucosa. Clin Exp Immunol 1980;42:273-279.
103. + αβ T cells in scid mice with colitis. Eur J Immunol 1996;16:3074-3083.
104. MacDonald T, Spencer J. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J Exp Med 1988;167:1341-1349.
105. + T cells and tissue damage in human small intestine by the bacterial superantigen, Staphylococcus aureus enterotoxin B. Eur J Immunol 1993;23:664-668.
106. Strober W, Ehrhardt RO. Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell 1993;75:203-205.
107. Powrie F. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 1995;3:171-174.
108. + T cells. J Exp Med 1993;178:237-244.
109. + lymphocyte populations with different T cell receptors: a role for the gut epithelium in T cell differentiation. J Exp Med 1991;173:471-478.
110. Lefrancois L. Intraepithelial lymphocytes of the intestinal raucosa: curiouser and curiouser. Semin Immunol 1991;3:99-108.
111. p) integrins on mouse lymphocytes: relevance to the mucosal immune system. Eur J Immunol 1991;21:2591-2597.
112. Kilshaw P. Expression of the mucosal T cell integrin alpha M290 beta 7 by a major subpopulation of dendritic cells in mice. Eur J Immunol 1993;23:3365-3368.
113. Cerf-Bensussan N, Begue B, Gagnon J, Meo T. The human intraepithelial lymphocyte marker HML-1 is an integrin consisting of a beta 7 subunit associated with a distinctive alpha chain. Eur J Immunol 1992;22:273-277.
114. Shaw S, Cepek KL, Murphy EA, Russell GJ, Brenner MB, Parker CM. Molecular cloning of the human mucosal lymphocyte integrin alpha E subunit. Unusual structure and restricted RNA distribution. J Biol Chem 1994;269:6016-6025.
115. 7 integrins on human mucosal lymphocytes. Proc Natl Acad Sci USA 1992;89:1924-1928.
116. 7 integrin. Nature 1994;372:190-193.
117. Hermiston M, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995;270:1203-1207.
118. Viney JL, MacDonald TT, Kilshaw PJ. T cell receptor expression in intestinal intraepithelial lymphocyte subpopulations of normal and athymic mice. Immunology 1989;66:583-587.
119. De Geus B, Van den Enden M, Coolen C, Nagelkerken L, Van der Heijden P, Rozing J. Phenotype of intraepithelial lymhocytes in euthymic and athymic mice: Implications for differentiation of cells bearing a CD3-associated γδ T cell receptor. Eur J Immunol 1990;20:291-298.
120. Bucy RP, Chen C-LH, Cihak J, Lösch U, Cooper MD. Avian T cells expressing γδ receptors localise in the splenic sinusoids and the intestinal epithelium. J Immunology 1988;141:2200-2205.
121. Mackay C, Hein WR. A large proportion of bovine T cells express the gamma delta T cell receptor and show a distinct tissue distribution and surface phenotype. Int Immunol 1989;1:540-545.
122. Imaoka A, Matsumoto S, Setoyama H, Okada Y, Umesaki Y. Proliferative recruitment of intestinal intraepithelial lymphocytes after microbial colonization of germ-free mice. Eur J Immunol 1996;26:945-948.
123. Kawaguchi-Miyashita M, et al. Development and cytolytic function of intestinal intraepithelial T lymphocytes in antigen-minimized mice. Immunology 1996;89:268-273.
124. Umesaki Y, Setoyama H, Matsumoto S, Okada Y. Expansion of αβ-TcR bearing intestinal intraepithelial lymphocytes after microbial colonization in germ-free mice and its independence from the thymus. Immunology 1993;79:32-37.
125. + intraepithelial lymphocytes. Science 1989;243:1716-1718.
126. Bandeira A, et al. Localization of γ/δ T cells in the intestinal epithelium is independent of normal microbial colonization. J Exp Med 1990;172:239-244.
127. Takeuchi M, Miyazaki H, Mirokawa K, Yokokura T, Yoshikai Y. Age-related changes of T cell subsets in intestinal intraepithelial lymphocytes of mice. Eur J Immunol 1993;23:1409-1411.
128. + phenotypes are increased in coeliac disease. Scand J Immunol 1989;30:665-672.
129. Viney J, MacDonald TT, Spencer J. γ/δ T cells in the gut epithelium. Gut 1990;31:841-844.
130. Spencer J, Isaacson PG, Diss TC, MacDonald TT. Expression of disulfide-linked and non-disulfide-linked forms of the T cell receptor γ/δ heterodimer in human intestinal intraepithelial lymphocytes. Eur J Immunol 1989;19:1335-1338.
131. Savilahti E, Arato A, Verkasalo M. Intestinal γ/δ receptor-bearing T lymphocytes in celiac disease and inflammatory bowel diseases in children. Constant increase in celiac disease. Pediatr Res 1990;28:579-581.
132. Maloy K, Mowat AM, Zamoyska R, Crispe IN. Phenotypic heterogeneity of intraepithelial T lymphocytes from mouse small intestine. Immunology 1991;72:555-562.
133. + CD2-cells and high expression of the RT6 alloantigen. Eur J Immunol 1991;21:755-760.
134. Van Houten N, Mixter PF, Wolfe J, Budd RC. CD2 expression on murine intestinal intraepithelial lymphocytes is bimodal and defines proliferative activity. Int Immunology 1993;5:665-672.
135. Trejdosiewicz LK, et al. Expression of T-cell receptors TcR1 (γ/δ) and TcR2 (α/β) in the human intestinal mucosa. Immunology 1989;68:7-12.
136. Mowat AM. Human intraepithelial lymphocytes. Springer Semin Immunopathol 1990;12:165-190.
137. Ohteki T, MacDonald HR. Expression of the CD28 costimulatory molecule on subsets of murine intestinal intraepithelial lymphocytes correlates with lineage and responsiveness. Eur J Immunol 1993;23:1251-1256.
138. + T cells from large intestine: implications for functional state. J Exp Med 1994;180:433-444.
139. -/- mutant mice and identification of a novel T cell population in the intestine. EMBO J 1993;12:4863-4875.
140. + murine intestinal intraepithelial lymphocytes can mediate perforin-based cytotoxicity, whereas both subsets are active in fas-based cytotoxicity. J Immunol 1996;157:35-41.
141. + TcRαβ intestinal intraepihelial lymphocytes in athymic nu/nu mice and participation in regional immune responses. Immunology 1996;88:531-536.
142. Park SY, et al. Differential contribution of the FcR γ chain to the surface expression of the T cell receptor among T cells localized in epithelia; analysis of FcR γ-deficient mice. Eur J Immunol 1995;25:2107-2110.
143. Guy-Grand D, et al. Different use of T cell receptor transducing modules in two populations of gut intraepithelial lymphocytes are related to distinct pathways of T cell differentiation. J Exp Med 1994;180:673-679.
144. Malissen M, et al. T cell development in mice lacking the CD3-ζ/η gene. EMBO J 1993;12:4347-4355.
145. Latthe M, Terry L, MacDonald TT. High frequency of CD8αα homodimer-bearing T cells in human fetal intestine. Eur J Immunol 1994;24:1703-1705.
146. Balk SP, et al. Composition of TcR-CD3 complex in human intestinal intraepithelial lymphocytes: lack of FcR epsilon R1 γ chain. Int Immunol 1995;7:1237-1241.
147. Ebert EC. Proliferative responses of human intraepithelial lymphocytes to various T cell stimuli. Gastroenterology 1989;97:1372-1381.
148. Mowat AM, McInnes IB, Parrott DMV. Functional properties of intraepithelial lymphocytes from mouse small intestine. IV. Investigation of the proliferative capacity of IEL using phorbol ester and calcium ionophore. Immunology 1989;66:398-405.
149. Mowat AM, MacKenzie S, Baca ME, Felstein MV, Parrott DMV. Functional characteristics of intraepithelial lymphocytes from mouse small intestine. II. In vivo and in vitro responses of intraepithelial lymphocytes to mitogenic and allogeneic stimuli. Immunology 1986;58;627-633.
150. Mosley RL, Whetsell M, Klein JR. Proliferative properties of murine intestinal intraepithelial lymphocytes (IEL): IEL expressing TcRαβ or TcRγδ are largely unresponsive to proliferative signals mediated via conventional stimulation of the CD3-TcR complex. Int Immunol 1991;3:563-569.
151. Viney JL, MacDonald TT. Lymphokine secretion and proliferation of intraepithelial lymphocytes from murine small intestine. Immunology 1992;77:19-24.
152. Sydora BC, et al. Intestinal intraepithelial lymphocytes are activated and cytolytic but do not proliferate as well as other T cells in response to mitogenic stimuli. J Immunol 1993;150:2179-2191.
153. 7 integrin. Eur J Immunol 1994;24:2832-2841.
154. + counterparts in coeliac disease. Immunology 1990;71:460-166.
155. Guy-Grand D, Malassis-Seris M, Briottet C, Vassalli P. Cytotoxic differentiation of mouse gut thymodependent and independent intraepithelial T lymphocytes is induced locally. Correlation between functional assays, presence of perforin and granzyme transcripts, and cytoplasmic granules. J Exp Med 1991;173:1549-1552.
156. + T cells in murine intestinal epithelium. Eur J Immunol 1990;20:1623-1626.
157. + intraepithelial lymphocytes, lytic for parasite-infected enterocytes. J Immunol 1994;153:4596-4603.
158. Cuff CF, Cebra CK, Rubin DH, Cebra JJ. Developmental relationship between cytotoxic α/β T cell-receptor - positive intraepithelial lymphocytes and Payer's patch lymphocytes. Eur J Immunol 1993;23:1333-1339.
159. Guy-Grand D, Cuenod-Jabri B, Malassis-Seris M, Selz F, Vassalli P. Complexity of the mouse gut T cell immune system: identification of two distinct natural killer T cell intraepithelial lineages. Eur J Immunol 1996;26:2248-2256.
160. Lundqvist C, Melgir S, Yeung MM, Hammarstrom S, Hammarstrom ML. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions. J Immunol 1996;157:1926-1934.
161. Yamamoto S, Russ F, Texeira HC, Conradt P, Kaufmann SH. Listeria monocytogenes-induced γ interferon production by intestinal intraepithelial γ/δ T lymphocytes. Infection Immunity 1993;61:2154-2161.
162. Boismenu R, Havran WL. Modulation of epithelial cell growth by intraepithelial gamma delta T cells. Science 1994;266:1253-1255.
163. Zeh JM, et al. Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology 1994;110:1077-1083.
164. Sakai T, Ohara-Wagaki K, Tsuzuki K, Yoshikai Y. Host intraepithelial gd T lymphocytes present during acute graft-versus-host disease in mice may contribute to the development of enteropathy. Eur J Immunol 1995;25:87-91.
165. Komano H, et al. Homeostatic regulation of intestinal epithelia by intraepithelial gamma delta T cells. Proc Natl Acad Sci USA 1995;92:6147-6151.
166. + deficient mice display abnormal but distinct phenotypes toward a natural, widespread infection of the intestinal epithelium. Proc Natl Acad Sci USA 1996;93:11774-11779.
167. Janeway C. Frontiers of the immune system. Nature 1988;33:804-806.
168. Lefrancois L, Barrett TA, Havran WL, Puddington L. Developmental expression of the αIELβ7 integrin on T cell receptor gd and T cell receptor ab T cells. Eur J Immunol 1994;24:635-640.
169. + lymphocytes reveals a major extrathymic pathway of T cell differentiation. J Exp Med 1991;173:483-186.
170. Poussier P, Edouard P, Lee C, Binnie M, Julius M. Thymus-independent development and negative selection of T cells expressing TcR α/β in the intestinal epithelium. Evidence for distinct circulation patterns of gut and thymus derived T lymphocytes. J Exp Med 1992;176:187-199.
171. Poussier P, Teh HS, Julius M. Thymus-independent positive and negative selection of T cells expressing a major histocompatibility complex I restricted transgenic T cell receptor α/β in the intestinal epithelium. J Exp Med 1993;178:1947-1957.
172. Guehler SR, Bluestone JA, Barrett TA. Immune deviation of 2C transgenic intraepithelial lymphocytes in antigen-bearing hosts. J Exp Med 1996;184:493-503.
173. Barrett TA, Tatsumi Y, Bluestone JA. Tolerance of T cell receptor γ/δ cells in the intestine. J Exp Med 1993;177:1755-1762.
174. Fujihashi K, et al. γ/δT cell-deficient mice have impaired mucosal immunoglobulin A responses. J Exp Med 1996;183:1929-1935.
175. + intraepithelial lymphocytes in murine small intestine. Immunology 1995;86:212-218.
176. Blumberg RS, Yockey CE, Gross GG, Ebert EC, Balk SP. Human intestinal intraepithelial lymphocytes are derived from a limited number of T cell clones that utilize multiple Vβ T cell receptor genes. J Immunol 1993;150:5144-5153.
177. Regnault A, et al. The expansion and selection of T cell receptor αβ intestinal intraepithelial T cell clones. Eur J Immunol 1996;26:914-921.
178. Regnault A, Cumano A, Vassalli P, Guy-Grand D, Kourilsky P. Oligoclonal repertoire of the CD8αα and the CD8αβ TcR-α/β murine intestinal intraepithelial T lymphocytes: evidence for the random emergence of T cells. J Exp Med 1994;180:1345-1358.
179. Blumberg R, Balk SP. Intraepithelial lymphocytes and their recognition of nonclassical MHC molecules. Int Rev Immunol 1994;11:15-30.
180. Fichtelius KE, Yunis EJ, Good RA. Occurrence of lymphocytes within the gut epithelium of normal and neonatally thymectomised mice. Proc Soc Exp Biol 1968;128:185-188.
181. Griebel PJ, Hein WR. Expanding the role of Peyer's patches in B-cell ontogeny. Immunology Today 1996;17:30-39
182. Poussier P, Julius M. Intestinal intraepithelial lymphocytes: the plot thickens. J Exp Med 1994;180:1185-1189.
183. Klein JR. Whence the intestinal intraepithelial lymphocyte? J Exp Med 1996;184:1203-1206.
184. Bandeira A, et al. Extrathymic origin of intestinal intraepithelial lymphocytes bearing T-cell antigen receptor γδ. Proc Nat Acad Sci USA 1990;88:43-47.
185. Lin T, et al. Characteristics of fetal thymus-derived T cell receptor γδ intestinal intraepithelial lymphocytes. Eur J Immunol 1994;24:1792-1798.
186. + intestinal lymphocytes (IEL) and the extrathymic development of IEL. Eur J Immunol 1994;24:1080-1087.
187. + intestinal intraepithelial lymphocytes early in ontogeny. Eur J Immunol 1994;24:1785-1789.
188. Fuller B, Lefrancois L. Requirement for extrathymic class I histocompatibility antigens for positive selection of thymus-derived T lymphocytes. J Immunol 1995;155:2808-2811.
189. + intestinal intraepithelial T cells in β2-microglobulin and/or TAP-1 deficient mice. J Immunol 1996;156:2710-2715.
190. Mosley RL, Styre D, Klein JR. Differentiation and functional maturation of bone marrow derived intestinal epithelial T cells expressing membrane T cell receptor in athymic radiation chimeras. J Immunol 1990;145:1369-1375.
191. Lin T, Matsuzaki G, Kenai H, Nakumura T, Nomoto K. Thymus influences the development of extrathymically derived intestinal intraepithelial lymphocytes. Eur J Immunol 1993;23:1968-1974.
192. Rocha B, Vassalli P, Guy-Grand D. Thymic and extrathymic origins of gut intraepithelial lymphocyte populations in mice. J Exp Med 1994;180:681-686.
193. Guy-Grand D, Vanden Broecke C, Briottet C, Malassis-Seris M, Selz F, Vassalli P. Different expression of the recombination activity gene1 in various populations of thymocytes, peripheral T cells and gut thymus-independent intraepithelial lymphocytes suggests two pathways of T cell receptor rearrangement. Eur J Immunol 1992;22:505-510.
194. Croitoru K, et al. Presence of intraepithelial lymphocytes in mice with severe combined immunodeficiency disease. Eur J Immunol 1990;20:645-651.
195. Mosley RL, Klein JR. Peripheral engraftment of fetal intestine into athymic mice sponsors T cell development: direct evidence for thympoietic function of murine small intestine. J Exp Med 1992;176:1365-1373.
196. Lefrancois L, Puddington L. Extrathymic intestinal T-cell development: virtual reality? Immunology Today 1995;16:16-21.
197. Wang J, Klein JR. Hormonal regulation of extrathymic gut T cell development: involvement of thyroid stimulating hormone. Cell Immunol 1995;161:299-302.
198. Taplin M-E, Frantz ME, Canning C, Ritz J, Blumberg RS, Balk SP. Evidence against T cell development in the adult human intestinal mucosa based upon lack of terminal deoxynudeotidyl transferase expression. Immunology 1996;87:402-407.
199. + lympho-hemopoietic progenitors develop. J Exp Med 1996;184:1449-1459.
200. Peschon J, et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994;180:1955-1960.
201. Mowat AM. The regulation of immune responses to dietary protein antigens. Immunology Today 1987;8:93-98.
202. Mowat AM. Oral tolerance and regulation of immunity to dietary antigens. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, eds. Handbook of mucosal immunology. San Diego: Academic Press Inc, 1994:185-201.
203. Duchmann R, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995;102:448-455.
204. Duchmann R, Schmitt E, Knolle P, Meyer zum Büschenfelde KH, Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol 1996;26:934-938.
205. McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992;10:75-88.
206. Matzinger P. Tolerance, danger and the extended family. Ann Rev Immunol 1994;12:991-1045.
207. Weiner HL, et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Ann Rev Immunol 1994;12:809-838.
208. Garside P, Mowat AM. Mechanisms of oral tolerance. Critical Reviews in Immunology 1997 (in press).
209. Chen Y, Inobe J-I, Marks R, Gonnella P, Kuchroo VK, Weiner HL. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995;376:177-180.
210. Marth T, Strober W, Kelsall BL. High dose oral tolerance in ovalbumin TcR-transgenic mice: systemic neutralisation of interleukin 12 augments TGFβ secretion and T cell apoptosis. J Immunology. 1996 (in press).
211. Whitacre CC, Gienapp IE, Orosz CG, Bitar DM. Oral tolerance in experimental autoimmune encephalitis. III. Evidence for clonal anergy. J Immunol 1991;147:2155-2163.
212. Whitacre CC, Gienapp IE, Meyer A, Cox KL, Javed N. Oral tolerance in experimental autoimmune encephalomyelitis. Ann NY Acad Sci 1996;778:217-227.
213. Javed NH, Gienapp IE, Cox KL, Whitacre CC. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis. J Immunol 1995;155:1599-1605.
214. Melamed D, Fischmann-Lobell J, Uni Z, Weiner HL, Friedman A. Peripheral tolerance of Th2 lymphocytes induced by continuous feeding of ovalbumin. Int Immunology 1996;8:717-724.
215. Melamed D, Friedman A. Direct Evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol 1993;23:935-942.
216. Friedman A, Weiner HL. Induction of anergy or active suppression following oral tolerance is determined by antigen doseage. Proc Natl Acad Sci USA 1994;91:6688-6692.
217. Van Houten N, Blake SF. Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J Immunol 1996;157:1337-1341.
218. Miller SD, Hanson DG. Inhibition of specific immune responses by feeding protein antigens. IV Evidence for tolerance and specific active suppression of cell-mediated immune responses to ovalbumin. J Immunol 1979;123:2344-2350.
219. Mattingly JA, Waksman BH. Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration. J Immunol 1978;121:1878-1883.
220. + T lymphocytes. J Immunol 1989;142:748-752.
221. McMenamin C, McKersey M, Kuhnlein P, Hunig T, Holt PG. γδ T cells down-regulate primary IgE responses in rats to inhaled soluble protein antigens. J Immunol 1995;154:4390-4394.
222. + cells suppress experimental autoimmune uveitis. Eur J Immunol 1996;26:2140-2148.
223. Mengel J, Cardillo F, Aroeira LS, Williams O, Russo M, Vaz NM. Anti-γδ T cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice. Immunology Letters 1995;48:97-102.
224. Ke Y, Pearce K, Lake JP, Ziegler HK, Kapp JA. γδ T lymphocytes regulate the induction of oral tolerance. J Immunology 1997 (in press).
225. Fishman-Lobell J, Friedman A, Weiner HL. Different kinetic patterns of cytokine gene expression in vivo in orally tolerant mice. Eur J Immunol 1994;24:2720-2724.
226. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down-regulation of inflammatory cytokines and differential up-regulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992;176:1355-1364.
227. Chen Y, Kuchroo VK, Inobe J-I, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-1240.
228. + cells mediate active suppression. J Immunol 1995;155:910-916.
229. Miller A, Roberts A, Sporn M, Lider O, Weiner HL. In vivo administration of anti-TGFβ antibody increases the severity and duration of experimental allergic enchephalomyelitis (EAE) and reverses suppression of EAE by oral tolerance to MBR Ann Neurol 1991;30:303 (Abstract).
230. Garside P, et al. Oral tolerance in mice is associated with increased susceptibility of challenged lymphocytes to undergo apoptosis in vivo. Am J Path 1996 (in press).
231. + cells on the induction and maintenance of oral tolerance. Cellular Immunology 1995;163:19-29.
232. + T cells are required for the induction of oral tolerance. Int Immunol 1995;7:501-504.
233. Vistica BP, et al. CD8 T-cells are not essential for the induction of "low dose" oral tolerance. Clin Immunol Immunopathol 1996;78:196-202.
234. + suppressor T cells. J Immunol 1996;156:916-921.
235. Nagler-Anderson C, Bober LA, Robinson ME, Siskind GW, Thorbecke GJ. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II antigen. Proc Nat Acad Sci USA 1986;83:7443-7446.
236. Thompson HSG, Staines NA. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol 1986;64:581-586.
237. Higgins PJ, Weiner H. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 1988;140:440-445.
238. Whitacre CC, Gienapp IE, Zhang X, Heber-Katz E. Oral tolerance in experimental autoimmune encephalomyelitis (EAE): A search for the MBP-specific T cell receptor. FASEB J 1990;4:A1856.
239. Nussenblatt RB, et al. Intraocular inflammatory disease (uveitis) and the use of oral tolerance. A status report. Ann NY Acad Sci 1996;778:325-337.
240. Nussenblatt RB, et al. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by induction of oral tolerance with S-antigen. J Immunol 1990;144:1689-1696.
241. Peterson KE, Braley-Mullen H. Suppression of murine experimental autoimmune thyroiditis by oral administration of porcine thyroglobulin. Cellular Immunology 1995;166:123-130.
242. Hancock WW, Polanski M, Zhang J, Blogg N, Weiner HL. Suppression of insulitis in nonobese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-β, and prostaglandin-E. American Journal of Pathology 1995;147:1193-1199.
243. Trentham DE, et al. Effects of oral administration of collagen on rheumatoid arthritis. Science 1993;261:1727-1730.
244. Weiner HL, et al. Double-blind pilot trial of tolerization with myelin antigens in multiple sclerosis. Science 1993;259:1321-1324.
245. Sieper J, et al. Oral type II collagen treatment in early rheumatoid arthritis. A double blind, placebo-controlled, randomized trial. Arthritis and Rheumatism 1996;39:41-51.
246. Dahlman-Hoglund A, Dahlgren U, Ahlstedt S, Hanson LA, Telemo E. Bystander suppression of the immune response to human serum albumin in rats fed ovalbumin. Immunology 1995;86:128-133.
247. Miller A, Lider O, Weiner HL. Antigen-driven bystander suppression following oral administration of antigens. J Exp Med 1991;174:791-798.
248. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc Nat Acad Sci USA 1992;89:421-425.
249. Elson C, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344-1367.
250. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993;22:274-282.
251. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-260.
252. Kuhn R, Lohler J, Rennick D, Rajowsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-279.
253. Rudolph U, et al. Gi2α protein deficiency: a model of inflammatory bowel disease. J Clin Immunol 1995;15:101S-105S.
254. Hollander G, et al. Severe colitis in mice with aberrant thymic selection. Immunity 1995;3:27-38.
255. Taurog J, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994;180:2359-2364.
256. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993;5:1461-1471.
257. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 1994;179:589-600.
258. + T cells. Nature 1994;369:654-658.
259. Mizoguchi A, et al. Cytokine imbalance and autoantibody production in T cell receptor-α mutant mice with inflammatory bowel disease. J Exp Med 1996;183:847-856.
260. Neurath MF, Fuss I, Kelsall BL, Stuber EA, Strober W. Antibodies to IL-12 abrogate established experimental colitis in mice. J Exp Med 1995;182:1281-1290.
261. + T cells are responsible for murine interleukin-2-deficient colitis. Eur J Immunol 1995;25:2618-2625.
262. + TH1-like responses. J Clin Invest 1996;98:1010-1020.
263. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 1996;184:241-251.
264. + bone-marrow-derived cells are the stimulus for the intestinal phase of the murine graft-versus-host reaction. Transplantation 1986;42:141-144.
265. Marsh M. Grains of truth: evolutionary changes in small intestinal mucosa in response to environmental antigen challenge. Gut 1990;31:111-114.
266. Mowat AM. Intestinal graft-versus-host disease. In: Ferrara SJBJ, ed. In graft versus host disease. New York: Marcel Dekker, 1996 (in press).
267. + T cells. Immunity 1994;1:553-562.
268. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995;101:428-435.
269. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996;157:1261-1270.
270. Kontakou M, Sturgess RP, Przemioslo RT, Limb GA, Nelufer JM, Ciclitira PJ. Detection of interferon γ mRNA in the mucosa of patients with coeliac disease by in situ hybridisation. Gut 1994;35:1037-1041.
271. Mowat AM. Antibodies to γ interferon prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology 1989;68:18-23.
272. Breese E, et al. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994;106:1455-1466.
273. Mowat A, Widmer MB. A role for IL-4 in immunologically mediated enteropathy. Clin Exp Immunol 1995;99:65-69.
274. Garside P, Hutton AK, Severn A, Liew FY, Mowat A. Nitric oxide mediates intestinal pathology in graft-vs.-host disease. Eur J Immunol 1992;22:2141-2145.
275. Mowat A, Hutton AK, Garside P, Steel M. A role for interleukin-1 α in immunologically mediated intestinal pathology. Immunology. 1993;80:110-115.
276. Pender S, Lionetti P, Murch SH, Wathan N, MacDonald TT. Proteolytic degradation of intestinal mucosal extracellular matrix after lamina propria T cell activation. Gut 1996;39:284-290.
277. + T cells. J Exp Med 1996;183:2669-2674.
278. Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J Exp Med 1996;183:2605-2616.